Increasing Awareness of Insomnia
Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder
Long-Term Data on Daridorexant, Suvorexant, and Lemborexant
Leslie Citrome, MD, MPH, comments on long-term data for daridorexant, suvorexant, and lemborexant.
Daridorexant Trials for Insomnia Treatment
Experts discuss daridorexant efficacy and safety data, and dosing considerations and what to communicate with patients when using daridorexant for insomnia.
Dual Orexin Receptor Antagonists (DORAs) in Treatment of Insomnia
Drs Paul Doghramji and Leslie Citrome provide an overview of dual orexin receptor antagonists (DORAs), suvorexant, lemborexant, and daridorexant, in treatment of insomnia disorder.
Sleep and Wakefulness Signals in Insomnia
Drs Paul Doghramji and Leslie Citrome discuss the sleep and wakefulness signals and pathways that contribute to insomnia.
Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) and Patient Reported Outcomes
Drs Paul Doghramji and Leslie Citrome review the use of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) to assess treatment efficacy.
Treatment of Insomnia and Comorbidities
Experts discuss treatment for patients experiencing insomnia in conjunction with other health conditions.
Pharmacological Treatment Options for Insomnia
Drs Paul Doghramji and Leslie Citrome review prescription drugs and over-the-counter remedies for treating insomnia.
Non-pharmacological Treatment Options for Insomnia:
Experts highlight cognitive behavioral therapy for insomnia (CBTI) and sleep hygiene as nonpharmacological approaches to the treatment of insomnia.
Quality of Life for Patients with Insomnia
Drs Paul Doghramji and Leslie Citrome discuss daytime sleepiness and other symptoms of insomnia and their impact on quality of life.
Co-occurrence of Insomnia With Other Health Conditions and Risk Factors and Triggers for Insomnia
Experts review the co-occurrence of insomnia with other medical conditions and discuss risks and triggers that lead to insomnia, such as age and psychiatric conditions.
Overview and Prevalence of Insomnia
Drs Paul Doghramji and Leslie Citrome provide an overview of the diagnosis and prevalence of insomnia.
2 Clarke Drive Cranbury, NJ 08512